ArticleEuropean journal of medical research2025
Oralcanreg registry: development and evaluation of an oral and lip squamous cell cancer registry.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe project aims to develop and evaluate a cancer registration system specifically designed for lip and oral squamous cell cancer. METHOD AND MATERIAL: First, a questionnaire created by the researcher was used to extract the registry design information pieces. Second, we designed the registry system using a variety of tools and technologies. PHP is selected as the server-side programming language, MariaDB is selected as the database management system, and CentOS 8 is selected as the base system. Web pages are designed and interacted with by users using HTML, CSS, and JavaScript. Thirdly, 21 clinical specialists who are the system's end users assessed the system using a standard questionnaire.
resultsPatient demographic and clinical data, information about medications administered, preliminary diagnostic evaluations, biopsy results, diagnosis-related tumor staging, clinical tumor features, surgical procedures, histopathological tumor features, pathologic stage classification, radiotherapy information, follow-up data, and disease registry functionalities are the main Minimum Data Sets (MDSs). The system is called "Oralcanreg," which is an acronym for the Oral Cancer Registry system. The software that was developed got data that was not always complete in all parts. The lowest one, "Diagnostic assessment," only made up 0.47% of the total data and had 96.8% missing values. This could be because these evaluations were not done or not recorded. Based on the average ratings for the system's overall scores in the [3-5] range, it can be said that the people who took part in the study regarded the registry's total function as "good."
conclusionDisease registration design and implementation provide benefits such as timely access to medical records.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.